semaglutide trevogrumab and garetosmab Are myostatin inhibitors the end of weight lifting? Not so fast! These drugs may end up being pretty cool, but we need to study them extensively. This phase 2 study showed some interim results looking semaglutide #tirzepatide #cardiovascularcomplications #bodyweight #diabetes

Eating large meals, especially before lying down, increases pressure on the stomach, making reflux more likely

That said, long-term use requires periodic evaluation

Specific pharmacy partners not disclosed to patients

Call a provider if: side effects are getting stronger instead of weaker you cannot eat or drink enough to stay hydrated you lose weight so fast that you feel weak and unwell you have ongoing pain that does not make sense Going to urgent or emergency care is important if you have: trouble breathing chest pain sudden, strong stomach pain signs of a severe allergic reaction Who Should Be More Careful with GLP-1 Medicines GLP-1 medicines are not the right fit for everyone

[2] A 2025 randomised phase 1 trial in adults with overweight or obesity found that tirzepatide reduced overall appetite, food cravings, tendency to overeat, perceived hunger and reactivity to foods in the environment, while not increasing cognitive restraint